Gt Biopharma, INC. (GTBP) SEC Filings — 2024
19 SEC filings for Gt Biopharma, INC. (GTBP) in 2024.
Filings
- GT Biopharma Files S-1 Registration — S-1 · Dec 23, 2024
- GT Biopharma Faces Delisting Concerns — 8-K · Nov 27, 2024
- GT Biopharma Files 8-K for Material Agreement — 8-K · Nov 21, 2024
- GT Biopharma Files Q3 2024 10-Q — 10-Q · Nov 14, 2024
- GT Biopharma Reports Director and Officer Changes — 8-K · Sep 16, 2024
- Gt Biopharma, INC. 10-Q Filing — 10-Q · Aug 14, 2024
- GT Biopharma Files 8-K — 8-K · Jun 27, 2024
- GT Biopharma Files 8-K on Security Holder Vote Matters — 8-K · Jun 26, 2024
- GT Biopharma Files S-1 Registration Statement — S-1 · Jun 20, 2024
- GT Biopharma Files Additional Proxy Materials — DEFA14A · Jun 17, 2024
- GT Biopharma Reports Director/Officer Changes and Compensation — 8-K · Jun 7, 2024
- Gt Biopharma, INC. SC 13G/A Filing — SC 13G/A · May 23, 2024
- GT Biopharma Files 8-K: Material Agreement & Equity Sales — 8-K · May 23, 2024
- GT Biopharma, Inc. Files 10-Q for Period Ending March 31, 2024 — 10-Q · May 15, 2024
- GT Biopharma Enters Material Definitive Agreement — 8-K · Apr 30, 2024
- GT Biopharma, Inc. Announces Annual Meeting of Stockholders on June 25, 2024 — DEF 14A · Apr 29, 2024
- GT Biopharma, Inc. Files 2023 Annual Report on Form 10-K — 10-K · Mar 26, 2024
- Gt Biopharma, INC. SC 13G/A Filing — SC 13G/A · Feb 14, 2024
- GT Biopharma Files 8-K: Security Holder Rights, Bylaw Amendments — 8-K · Feb 1, 2024